Relationship between receptor status and end results in treatment of endometrial carcinoma

Voprosy Onkologii

Volumn 52, Issue 6, 2006, Pages 654-658

  Bainazarova, A A ^a   Iskakova, Zh K ^a  

^a Kazakh Veterinary Research Institute   (Kazakhstan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MIDDLE AGED; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33947719751     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Capobianco G., Cherchi P. L., Demurtas P. et al. Prognostic value of P-53, C-erb-B2 and MIB-1 in endometrial carcinoma//Int. J. Gynecol. Cancer-2003.-Vol. 13.-P. 81-.
10. Pavare I., Baltina D., Zvaigstine M. Prevalence of estrogen and progesterone receptors in endometrial cancer // Ann. oncol.-1996.-Vol. 7.-P. 74-.